Innovative research has provided compelling evidence that perceived stress can directly trigger the relapse of psoriatic skin ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

Nov. 12, 2024 — Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other ...

It’s perfectly acceptable, however, for doctors to prescribe a medicine to treat another condition. This is called “off-label use.” TCIs can be extremely helpful for some people who have psoriasis.

PSORIASIS, a chronic immune-mediated skin condition, poses a significant challenge for patients, with an ongoing unmet need for effective biologic treatments. To address this, a recent randomised ...

2009.0011 Key words: psoriasis, treatment concept, genetics, immune-mediated inflammatory disease, guidelines Recent scientific advances have led to new concepts of the pathogenesis of psoriasis ...

Opens in a new tab or window A derivative of the diuretic drug amiloride (Midamor) blocked key inflammatory pathways in mouse models of psoriasis, including xenografts of psoriatic human skin ...

It comes from vitamin A. Patients with severe psoriasis who test positive for HIV (human immunodeficiency virus) Unlike other medicine for severe psoriasis, oral retinoids do NOT suppress the immune ...

“One person thinks it’s the bone marrow and another thinks it’s the T cells, so we haven’t quite put it all together to have a definitive answer.” Personalized medicine in psoriasis and ...

China: A new randomized clinical trial has demonstrated that QX004N, a humanized anti-IL-23 monoclonal antibody, offers superior safety and efficacy compared to a placebo in patients with moderate to ...

Objective We aimed to investigate the relationship between tumour necrosis factor inhibitors (TNFi) therapy and the onset of new psoriasis in children with juvenile idiopathic arthritis (JIA) using ...

Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients with cancer undergoing immune checkpoint inhibitor (ICI) treatments ...